Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 49 for your search:
Cancer Type/Condition:
breast cancer, male breast cancer
Trial Type:
Screening, Prevention
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations
Phase:
Phase IV
Type:
Screening
Status:
Active
Age:
25 to 70
Sponsor:
Other
Protocol IDs:
DBCG07MRBRCA
, DBCG07MRBRCA, NCT00413491
2.
Phase III Randomized Study of Exemestane in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
35 and over
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
CAN-NCIC-MAP3
, PFIZER-EXEAPO-0028-150, ExCel, NCT00083174, MAP3
3.
Partnership for Healthy Seniors
Phase:
Phase III
Type:
Educational/Counseling/Training, Screening, Treatment
Status:
Active
Age:
65 and over
Sponsor:
Other
Protocol IDs:
IRB00000063
, NCT00379743
4.
Phase III Randomized Study of Continuous Letrozole Versus Intermittent Letrozole in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive, Early-Stage Breast Cancer After Completion of 4 to 6 Years of Prior Adjuvant Endocrine Therapy
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
Postmenopausal
Sponsor:
Other
Protocol IDs:
IBCSG-35-07
, IBCSG-35-07, BIG-1-07-SOLE, EUDRACT-2007-001370-88, NCT00553410
5.
Phase III Randomized Study of Letrozole in Preventing Breast Cancer in Postmenopausal Women With the BRCA1/BRCA2 Mutation
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
40 to 69
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
FNCLCC-ONCO-03/0701
, FNCLCC-ONCO 03/0701 - LIBER, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, NCT00673335
6.
Randomized Study of Prophylactic Cranial Radiotherapy in Women With Metastatic or Locally Advanced Breast Cancer Previously Treated With Trastuzumab (Herceptin®) and Taxane Chemotherapy
Phase:
Phase III
Type:
Prevention, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
ACCOG-HER-PCI
, ACCOG-HER-PCI, ISRCTN64624715, EU-20822, NCT00639366
7.
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
30 to 75
Sponsor:
Other
Protocol IDs:
GD-10-08
, NCT00808522
8.
Phase III Prospective Pilot Study of Positron Emission Mammography and Conventional Two-View Digital Mammography in Women With Dense Breast Tissue or Who Are at High Risk for Breast Cancer
Phase:
Phase III
Type:
Screening
Status:
Active
Age:
35 and over
Sponsor:
Other
Protocol IDs:
BUMC-H-27136
, H-27136, CDMRP #W81XWH-06-1-0309, 05063002, HRPO #A-13777.2, NCT00896649
9.
Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
12 to 26
Sponsor:
Other
Protocol IDs:
RCH CA27091
, NCT00964210
10.
Use of Hair to Diagnose Breast Cancer
Phase:
Phase II, Phase I
Type:
Screening
Status:
Active
Age:
20 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
FT3.6k-2006
, NCT00419679
11.
Use of Hair to Diagnose the Presence of Breast Cancer
Phase:
Phase II, Phase I
Type:
Screening
Status:
Active
Age:
20 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
FER2k
, NCT00419900
12.
Phase II Pilot Chemoprevention Study of Deslorelin in Combination With Low-Dose Add-Back Estradiol and Testosterone in Premenopausal Women With or Without a BRCA Gene Mutation Who Are at High Risk for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
21 to 48
Sponsor:
NCI
Protocol IDs:
CHNMC-IRB-02164
, NCT00080756
13.
Phase II Study of Exemestane in Postmenopausal Women at High Risk for Invasive Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
Postmenopausal
Sponsor:
NCI
Protocol IDs:
GUMC-2007-313
, NCI-04-C-0044, NCT00085072, GUMC-2007-313, GT 07-313, 2007-313
14.
Soy Protein and Breast Cancer Risk Reduction
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 40
Sponsor:
Other
Protocol IDs:
02-422
, Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, NIH NCRR GCRC M01 RR00073, NCT00204477
15.
Soy Isoflavones and Breast Cancer Risk Reduction
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 42
Sponsor:
NCI, Other
Protocol IDs:
03-260
, UTMB GCRC #635, NIH R01-CA95545, NIH NCRR GCRC M01 RR00073, NCT00204490
16.
Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Diagnostic, Prevention
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
BRSNSTU0010
, NCT00285857
17.
Phase II Chemoprevention Study of Simvastatin in Women at High Risk of Developing a New Breast Cancer After Undergoing Surgical Resection for Ductal Carcinoma in Situ or Stage I-III Invasive Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J0485
, J0485, JHOC-SKCCC-J0485, JHOC-04100404, NCT00334542
18.
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Approved-not yet active
Age:
30 to 90
Sponsor:
Other
Protocol IDs:
102/07
, NCT00496288
19.
Randomized Study of the Early Detection of Breast and Cervical Cancer in Women in India
Phase:
Phase II
Type:
Educational/Counseling/Training, Screening
Status:
Active
Age:
35 to 64
Sponsor:
NCI
Protocol IDs:
TATA-1900215717A1
, 1900215717A1, NCT00632047
20.
Study of Breast Cancer Prevention by Letrozole in High Risk Women
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 69
Sponsor:
NCI, Other
Protocol IDs:
10587
, NCT00579826
21.
Phase II Study of Acolbifene Hydrochloride in Premenopausal Women At High Risk for Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
30 to 55
Sponsor:
NCI
Protocol IDs:
WCCC-UW-CO06101
, KUMC-HSC-10588, KUMC HSC 10588, WCCC-UWI05-6-01, NCT00853996
22.
Vitamin D in Postmenopausal Women at High Risk for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
Protocol Dated 121308
, AAAD3638, NCT00859651
23.
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
RSRB00025478
, NCT00904033
24.
Statins and Breast Cancer Biomarkers
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
35 to 55
Sponsor:
Other
Protocol IDs:
V0407
, CHRMS#: 05-059, NCT00914017
25.
Green Tea and Reduction of Breast Cancer Risk
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
50 to 64
Sponsor:
NCI, Other
Protocol IDs:
0806M36121
, NCT00917735
Select All on Page
1
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
